Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Outcomes of Complex Percutaneous Cardiac Interventions in Women
Author(s): Mirvat Alasnag , Valeria Paradies , Nicola Ryan , et al Added: 4 months ago

Intervention
ACC 2021 Discussion: The ISCHEMIA Trial
Author(s): Gregg Stone , Harriette Van Spall Added: 2 years ago
Dr Gregg W Stone (Mount Sinai Heart Health System, New York, US) and Dr Harriette Van Spall (McMaster University, Hamilton, CA) discuss the latest results from the ISCHEMIA trial. The trial assessed the impact of completeness of revascularization on clinical outcomes in patients with stable ischemic heart disease treated with an invasive versus conservative strategy. Recorded remotely from New… View more

Anticoagulation

Vascular Disease and Surgery
Author(s): Yaser Nemshah , Alex Clavijo , Gyanendra Sharma Added: 3 years ago
Amyloidosis is a heterogenous group of disorders that develops secondary to the deposition of abnormally folded proteins, amyloid fibrils, in the extracellular space. Amyloidosis is classified according to the type of the precursor protein that results in the formation of amyloid fibrils. It can be inherited or acquired, and can involve multiple organs, including the heart. Amyloidosis that… View more

Heart Failure
Managing Failed Transcatheter Aortic Valve Replacement
Author(s): Nils Perrin , Anita W Asgar Added: 2 years ago

Intervention
Author(s): Marsha M Neumyer , Bill Bertolino Added: 3 years ago
There are numerous non-invasive tests available to assess lower-extremity peripheral arterial disease (PAD), but there remains some confusion among practitioners as to which non-invasive study should be performed on a given patient. A patient presenting with critical limb ischemia may warrant a different initial examination from a patient presenting with intermittent claudication or an… View more

Prevention & Chronic Conditions
Coarctation: A Review
Author(s): Marc G Cribbs Added: 3 years ago
The incidence of congenital heart disease (CHD) is slightly less than 1% of all live births.1 With extensive medical and surgical innovation over the past 50 years, and the high-quality care received in childhood, 85–90% of children with CHD in the US survive into adulthood. As a result, the number of adults with congenital heart defects in the US now exceeds 1 million, with a projected continued… View more

Heterogeneous Populations
Author(s): Somsupha Kanjanauthai , Kabir Bhasin , Luigi Pirelli , et al Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) has been established as a therapeutic option for patients with severe symptomatic aortic stenosis who are considered to be of intermediate, high or prohibitive surgical risk.1–5 As a result of favorable TAVR outcomes and substantial improvements in transcatheter heart valve (THV) technologies and implantation techniques, the feasibility of broadening… View more

Vascular Disease and Surgery

Electrophysiology & Arrhythmia
PARTNER 3: TAVR is Cost Effective Compared with SAVR for Low-Risk Patients
Author(s): David J Cohen Added: 2 years ago
Dr David J Cohen (St Francis Hospital, Roslyn, NY, US) discusses the findings from PARTNER 3 Economic Study. The study, presented first at TCT 2021, showed that for patients with severe AS and low surgical risk, TF-TAVR with the SAPIEN 3 valve is cost-saving compared with SAVR at 2-year follow-up. Discussion Points Importance of the Study Used Data Complexities in Relation to the Costs of… View more

Intervention
TCT 21: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB
Author(s): Bruno Scheller Added: 2 years ago
In this video, Professor Bruno Scheller (Saarland University, Saarbrücken, DE) sits down to discuss the one-year angiographic outcomes of two parallel randomized trials investigating the effectiveness off sirolimus-coated and paclitaxel-coated DCB's in the treatment of coronary in-stent restenosis. Findings suggest comparable outcomes in both devices. Discussion points: 1. Importance of this… View more

Intervention
Author(s): Rhian E Davies , J Dawn Abbott Added: 3 years ago
Percutaneous Coronary Intervention for Clinical Syndromes Stable Angina The primary benefit of percutaneous coronary intervention (PCI) over medical therapy in patients with stable angina is the improved quality of life. The PCI in stable angina (ORBITA) trial was the first sham-controlled trial of PCI where 200 medically optimized patients with single vessel disease were randomized to PCI or… View more

Intervention